Federal contract award
75F40121F19001
DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | B529 — Scientific Data Studies |
| Parent award / vehicle | 75F40121D00033 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $695.9K |
| Current contract value | $695.9K |
| Potential contract value / ceiling | $695.9K |
| Start date | Sep 30, 2021 |
| Current end date | Dec 29, 2026 |
| Potential end date | Dec 29, 2026 |
| Latest award activity | Aug 19, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 19, 2026 | P00009 | $0 | EO 14398 - DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| Jul 8, 2026 | P00008 | $0 | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| Apr 29, 2025 | P00007 | $133.7K | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| Jun 13, 2024 | P00006 | $0 | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| Mar 4, 2024 | P00005 | $129.8K | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| Jul 28, 2023 | P00004 | $0 | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| Mar 2, 2023 | P00003 | $126.1K | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| May 27, 2022 | P00002 | $0 | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| Mar 14, 2022 | P00001 | $122.4K | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
| Sep 30, 2021 | 0 | $183.8K | DATA RESOURCES FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2026-12-29 (58 days from calculation)
- +35 points
- 18 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2026-08-19
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.